June 2026
Proprietary AI analyst is now available
Largest Medical Imaging & Diagnostics Public Companies in Poland
Benchmark revenue and EBITDA valuation multiples for public comps like
Diagnostyka, Voxel, Scope Fluidics, Biomaxima and Genomed.
 | Diagnostyka SA is engaged in providing laboratory diagnostics services in Poland. The company offers comprehensive laboratory services from collecting biological material, through testing, to providing results online. | $46 | +1% | $2B | $2B | 2.8x | 11.2x | ||
| Voxel SA is a network of diagnostic imaging laboratories created for patients and to increase access to high-quality tests. The company operates diagnostic imaging centers and laboratories and provides several services such as magnetic resonance imaging, computed tomography and positron emission tomography. It has 33 specialised laboratories in 21 cities throughout Poland. | $31 | -29% | $326M | $375M | 2.3x | 7.2x | ||
| Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services. | $34 | -17% | $107M | $69M | 2537.6x | (5.8x) | ||
| BioMaxima SA is a Polish company operating in the market of laboratory diagnostics. It is a manufacturer of microbiological substrates as well as a wide range of reagents and diagnostic equipment. The company is also a distributor of products of recognized multinational diagnostic companies such as: Accelerate Diagnostics, Nova Biomedical, PHC Group, Technoclone, Kabe and Biolog. | $3 | -29% | $12M | $16M | 1.1x | 12.5x | ||
| Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes. | $7 | +0% | $9M | $8M | 0.9x | 5.7x | ||
| Brainscan SA is an AI system for lesion detection in the human brain based on computed tomography images. Algorithms powered by artificial intelligence analyze CT brain scans, automatically detecting and highlighting potential pathological changes. | $4 | -48% | $5M | $5M | 40.1x | (6.2x) | ||
| Median | $19 | -23% | $59M | $43M | 2.5x | 6.5x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.